drugset / Trial / NCT05604794

A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health

NCT05604794 ↗

Phase 4 Completed 1806 enrolled Field Trip Health
NaSingle-groupOpen-labelTreatment

Summary

Ketamine-Assisted Psychotherapy (KAP) is a relatively new approach for the treatment of mental health issues, which involves the combination of ketamine, a dissociative anaesthetic with psychedelic properties, and psychotherapy to promote emotional wellbeing. In this study, we investigated the effectiveness of KAP in adult patients coping with mental health. We predicted that clients would experience lasting reductions in psychological distress over time, such as depression, anxiety, and post traumatic stress, that would be detectable up to 6 months after treatment. The results of this study may provide evidence of sustained real-world effects of Ketamine-Assisted Psychotherapy, of interest to patients, clinicians, researchers, and policymakers.

Timeline

Start
2020-03-13
Primary completion
2022-06-16
Completion
2022-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — —